IBDEI2FT ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,38933,0)
 ;;=L03.012^^152^1990^103
 ;;^UTILITY(U,$J,358.3,38933,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38933,1,3,0)
 ;;=3^Cellulitis of Left Finger
 ;;^UTILITY(U,$J,358.3,38933,1,4,0)
 ;;=4^L03.012
 ;;^UTILITY(U,$J,358.3,38933,2)
 ;;=^5009020
 ;;^UTILITY(U,$J,358.3,38934,0)
 ;;=L03.021^^152^1990^25
 ;;^UTILITY(U,$J,358.3,38934,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38934,1,3,0)
 ;;=3^Acute Lymphangitis of Right Finger
 ;;^UTILITY(U,$J,358.3,38934,1,4,0)
 ;;=4^L03.021
 ;;^UTILITY(U,$J,358.3,38934,2)
 ;;=^5009022
 ;;^UTILITY(U,$J,358.3,38935,0)
 ;;=L03.022^^152^1990^19
 ;;^UTILITY(U,$J,358.3,38935,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38935,1,3,0)
 ;;=3^Acute Lymphangitis of Left Finger
 ;;^UTILITY(U,$J,358.3,38935,1,4,0)
 ;;=4^L03.022
 ;;^UTILITY(U,$J,358.3,38935,2)
 ;;=^5009023
 ;;^UTILITY(U,$J,358.3,38936,0)
 ;;=L03.031^^152^1990^113
 ;;^UTILITY(U,$J,358.3,38936,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38936,1,3,0)
 ;;=3^Cellulitis of Right Toe
 ;;^UTILITY(U,$J,358.3,38936,1,4,0)
 ;;=4^L03.031
 ;;^UTILITY(U,$J,358.3,38936,2)
 ;;=^5009025
 ;;^UTILITY(U,$J,358.3,38937,0)
 ;;=L03.032^^152^1990^106
 ;;^UTILITY(U,$J,358.3,38937,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38937,1,3,0)
 ;;=3^Cellulitis of Left Toe
 ;;^UTILITY(U,$J,358.3,38937,1,4,0)
 ;;=4^L03.032
 ;;^UTILITY(U,$J,358.3,38937,2)
 ;;=^5009026
 ;;^UTILITY(U,$J,358.3,38938,0)
 ;;=L03.041^^152^1990^27
 ;;^UTILITY(U,$J,358.3,38938,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38938,1,3,0)
 ;;=3^Acute Lymphangitis of Right Toe
 ;;^UTILITY(U,$J,358.3,38938,1,4,0)
 ;;=4^L03.041
 ;;^UTILITY(U,$J,358.3,38938,2)
 ;;=^5009028
 ;;^UTILITY(U,$J,358.3,38939,0)
 ;;=L03.042^^152^1990^21
 ;;^UTILITY(U,$J,358.3,38939,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38939,1,3,0)
 ;;=3^Acute Lymphangitis of Left Toe
 ;;^UTILITY(U,$J,358.3,38939,1,4,0)
 ;;=4^L03.042
 ;;^UTILITY(U,$J,358.3,38939,2)
 ;;=^5009029
 ;;^UTILITY(U,$J,358.3,38940,0)
 ;;=M34.0^^152^1990^289
 ;;^UTILITY(U,$J,358.3,38940,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38940,1,3,0)
 ;;=3^Progressive Systemic Sclerosis
 ;;^UTILITY(U,$J,358.3,38940,1,4,0)
 ;;=4^M34.0
 ;;^UTILITY(U,$J,358.3,38940,2)
 ;;=^5011778
 ;;^UTILITY(U,$J,358.3,38941,0)
 ;;=M34.1^^152^1990^92
 ;;^UTILITY(U,$J,358.3,38941,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38941,1,3,0)
 ;;=3^CR(E)ST Syndrome
 ;;^UTILITY(U,$J,358.3,38941,1,4,0)
 ;;=4^M34.1
 ;;^UTILITY(U,$J,358.3,38941,2)
 ;;=^5011779
 ;;^UTILITY(U,$J,358.3,38942,0)
 ;;=M34.2^^152^1990^313
 ;;^UTILITY(U,$J,358.3,38942,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38942,1,3,0)
 ;;=3^Systemic Sclerosis Induced by Drug/Chemical
 ;;^UTILITY(U,$J,358.3,38942,1,4,0)
 ;;=4^M34.2
 ;;^UTILITY(U,$J,358.3,38942,2)
 ;;=^5011780
 ;;^UTILITY(U,$J,358.3,38943,0)
 ;;=M34.81^^152^1990^315
 ;;^UTILITY(U,$J,358.3,38943,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38943,1,3,0)
 ;;=3^Systemic Sclerosis w/ Lung Involvement
 ;;^UTILITY(U,$J,358.3,38943,1,4,0)
 ;;=4^M34.81
 ;;^UTILITY(U,$J,358.3,38943,2)
 ;;=^5011781
 ;;^UTILITY(U,$J,358.3,38944,0)
 ;;=M34.82^^152^1990^316
 ;;^UTILITY(U,$J,358.3,38944,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38944,1,3,0)
 ;;=3^Systemic Sclerosis w/ Myopathy
 ;;^UTILITY(U,$J,358.3,38944,1,4,0)
 ;;=4^M34.82
 ;;^UTILITY(U,$J,358.3,38944,2)
 ;;=^5011782
 ;;^UTILITY(U,$J,358.3,38945,0)
 ;;=M34.83^^152^1990^317
